BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10998524)

  • 1. Tissue distribution of the opioid receptor-like (ORL1) receptor.
    Mollereau C; Mouledous L
    Peptides; 2000 Jul; 21(7):907-17. PubMed ID: 10998524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding.
    Neal CR; Mansour A; Reinscheid R; Nothacker HP; Civelli O; Akil H; Watson SJ
    J Comp Neurol; 1999 Oct; 412(4):563-605. PubMed ID: 10464356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of orphanin FQ/nociceptin and its receptor in rat peripheral ganglia and spinal cord.
    Pettersson LM; Sundler F; Danielsen N
    Brain Res; 2002 Aug; 945(2):266-75. PubMed ID: 12126889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nociceptin/orphanin FQ: role in nociceptive information processing.
    Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
    Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain.
    Neal CR; Akil H; Watson SJ
    J Chem Neuroanat; 2001 Nov; 22(4):219-49. PubMed ID: 11719021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
    Narita M; Mizoguchi H; Oji DE; Dun NJ; Hwang BH; Nagase H; Tseng LF
    Br J Pharmacol; 1999 Nov; 128(6):1300-6. PubMed ID: 10578145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of nociceptin/orphanin FQ precursor protein and receptor in brain and spinal cord: a study using in situ hybridization and X-gal histochemistry in receptor-deficient mice.
    Houtani T; Nishi M; Takeshima H; Sato K; Sakuma S; Kakimoto S; Ueyama T; Noda T; Sugimoto T
    J Comp Neurol; 2000 Aug; 424(3):489-508. PubMed ID: 10906715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of opioid receptor-like 1 (ORL1) & mu opioid receptors in the spinal cord of morphine tolerant mice.
    Ray SB; Gupta YK; Wadhwa S
    Indian J Med Res; 2005 Mar; 121(3):194-202. PubMed ID: 15802762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin.
    Ahmadi S; Liebel JT; Zeilhofer HU
    Eur J Pharmacol; 2001 Jan; 412(1):39-44. PubMed ID: 11166734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic localization of [3H]nociceptin binding sites in the rat brain.
    Florin S; Meunier J; Costentin J
    Brain Res; 2000 Oct; 880(1-2):11-6. PubMed ID: 11032985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
    Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
    J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray.
    Chiou LC
    J Biomed Sci; 2000; 7(3):232-40. PubMed ID: 10810242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternatively spliced transcript of the rat nociceptin receptor ORL1 gene encodes a truncated receptor.
    Xie G; Ito E; Maruyama K; Pietruck C; Sharma M; Yu L; Pierce Palmer P
    Brain Res Mol Brain Res; 2000 Apr; 77(1):1-9. PubMed ID: 10814826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice.
    Clarke S; Czyzyk T; Ansonoff M; Nitsche JF; Hsu MS; Nilsson L; Larsson K; Borsodi A; Toth G; Hill R; Kitchen I; Pintar JE
    Eur J Neurosci; 2002 Nov; 16(9):1705-12. PubMed ID: 12431223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions.
    Schulz S; Schreff M; Nüss D; Gramsch C; Höllt V
    Neuroreport; 1996 Nov; 7(18):3021-5. PubMed ID: 9116232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels.
    Murali SS; Napier IA; Rycroft BK; Christie MJ
    J Physiol; 2012 Apr; 590(7):1655-67. PubMed ID: 22371475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
    Mandyam CD; Thakker DR; Christensen JL; Standifer KM
    J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat.
    Czapla MA; Champion HC; Kadowitz PJ
    Peptides; 1997; 18(6):793-5. PubMed ID: 9285926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin/orphanin FQ metabolism and bioactive metabolites.
    Terenius L; Sandin J; Sakurada T
    Peptides; 2000 Jul; 21(7):919-22. PubMed ID: 10998525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.